LRRCC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.746000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.858000E-01
Normal-vs-Stage2
8.774000E-01
Normal-vs-Stage3
3.486200E-02
Normal-vs-Stage4
2.581800E-01
Stage1-vs-Stage2
9.960800E-01
Stage1-vs-Stage3
8.152400E-02
Stage1-vs-Stage4
1.615170E-01
Stage2-vs-Stage3
7.165600E-04
Stage2-vs-Stage4
7.605500E-02
Stage3-vs-Stage4
8.959600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.779000E-01
Normal-vs-AfricanAmerican
7.230800E-01
Normal-vs-Asian
4.915800E-01
Caucasian-vs-AfricanAmerican
7.825000E-01
Caucasian-vs-Asian
2.721000E-01
AfricanAmerican-vs-Asian
6.362800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.351400E-01
Normal-vs-Female
9.286600E-01
Male-vs-Female
6.416400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.674600E-01
Normal-vs-Age(41-60Yrs)
8.258200E-01
Normal-vs-Age(61-80Yrs)
7.494200E-01
Normal-vs-Age(81-100Yrs)
7.914600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.920800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.185200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.378200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.816000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.124800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.143200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.816000E-01
Normal-vs-Daily Drinker
6.427000E-01
Normal-vs-Weekly Drinker
5.118200E-01
Normal-vs-Occasional Drinker
8.892800E-01
Normal-vs-Social Drinker
6.197400E-01
Non Drinker-vs-Daily Drinker
8.169400E-01
Non Drinker-vs-Weekly Drinker
7.015200E-01
Non Drinker-vs-Occasional Drinker
6.324200E-01
Non Drinker-vs-Social Drinker
4.209900E-02
Daily Drinker-vs-Weekly Drinker
9.251000E-01
Daily Drinker-vs-Occasional Drinker
5.591400E-01
Daily Drinker-vs-Social Drinker
8.977900E-02
Weekly Drinker-vs-Occasional Drinker
5.104000E-01
Weekly Drinker-vs-Social Drinker
6.975700E-02
Occasional Drinker-vs-Social Drinker
2.875000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.755370E-01
Normal-vs-Grade 2
1.843800E-02
Normal-vs-Grade 3
5.460300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.606000E-02
Grade 1-vs-Grade 3
2.596100E-02
Grade 1-vs-Grade 4
1.755370E-01
Grade 2-vs-Grade 3
4.022400E-01
Grade 2-vs-Grade 4
1.843800E-02
Grade 3-vs-Grade 4
5.460300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.653800E-01
Normal-vs-NonDiabetic
7.563400E-01
Diabetic-vs-NonDiabetic
6.419000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.885600E-01
Normal-vs-NoPancreatitis
7.705000E-01
Pancreatitis-vs-NoPancreatitis
9.475800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.772200E-01
Normal-vs-N1
9.277600E-01
N0-vs-N1
7.850600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.615800E-01
Normal-vs-TP53-NonMutant
9.467000E-01
TP53-Mutant-vs-TP53-NonMutant
5.275600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
